Bank of New York Mellon’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$75.1M Sell
1,365,581
-12,983
-0.9% -$714K 0.01% 755
2025
Q1
$97.5M Sell
1,378,564
-1,021,389
-43% -$72.2M 0.02% 629
2024
Q4
$158M Buy
2,399,953
+79,964
+3% +$5.26M 0.03% 443
2024
Q3
$163M Sell
2,319,989
-18,104
-0.8% -$1.27M 0.03% 439
2024
Q2
$192M Sell
2,338,093
-299,395
-11% -$24.6M 0.04% 385
2024
Q1
$230M Buy
2,637,488
+77,249
+3% +$6.75M 0.04% 344
2023
Q4
$247M Buy
2,560,239
+165,099
+7% +$15.9M 0.05% 324
2023
Q3
$212M Buy
2,395,140
+207,665
+9% +$18.4M 0.05% 343
2023
Q2
$190M Buy
2,187,475
+107,826
+5% +$9.35M 0.04% 385
2023
Q1
$202M Buy
2,079,649
+375,850
+22% +$36.5M 0.04% 365
2022
Q4
$176M Buy
1,703,799
+557,851
+49% +$57.7M 0.04% 400
2022
Q3
$97.1M Sell
1,145,948
-204,566
-15% -$17.3M 0.02% 610
2022
Q2
$112M Buy
1,350,514
+607,467
+82% +$50.3M 0.03% 563
2022
Q1
$57.3M Buy
743,047
+40,159
+6% +$3.1M 0.01% 1012
2021
Q4
$62.1M Sell
702,888
-2,022
-0.3% -$179K 0.01% 1006
2021
Q3
$54.5M Buy
704,910
+10,066
+1% +$778K 0.01% 1073
2021
Q2
$58M Sell
694,844
-14,195
-2% -$1.18M 0.01% 1041
2021
Q1
$53.5M Sell
709,039
-41,475
-6% -$3.13M 0.01% 1067
2020
Q4
$65.8M Sell
750,514
-74,897
-9% -$6.57M 0.01% 886
2020
Q3
$62.8M Sell
825,411
-273,554
-25% -$20.8M 0.02% 784
2020
Q2
$136M Buy
1,098,965
+350,064
+47% +$43.2M 0.04% 431
2020
Q1
$63.3M Buy
748,901
+5,977
+0.8% +$505K 0.02% 652
2019
Q4
$62.8M Sell
742,924
-13,716
-2% -$1.16M 0.02% 848
2019
Q3
$51M Sell
756,640
-660,366
-47% -$44.5M 0.01% 934
2019
Q2
$121M Sell
1,417,006
-46,935
-3% -$4.02M 0.03% 514
2019
Q1
$130M Sell
1,463,941
-36,431
-2% -$3.24M 0.04% 468
2018
Q4
$128M Buy
1,500,372
+174,789
+13% +$14.9M 0.04% 422
2018
Q3
$129M Sell
1,325,583
-16,263
-1% -$1.58M 0.03% 510
2018
Q2
$126M Sell
1,341,846
-73,623
-5% -$6.94M 0.03% 495
2018
Q1
$115M Sell
1,415,469
-37,023
-3% -$3M 0.03% 524
2017
Q4
$130M Sell
1,452,492
-392,401
-21% -$35M 0.03% 505
2017
Q3
$172M Sell
1,844,893
-517,625
-22% -$48.2M 0.05% 394
2017
Q2
$215M Buy
2,362,518
+82,813
+4% +$7.52M 0.06% 334
2017
Q1
$200M Buy
2,279,705
+54,351
+2% +$4.77M 0.06% 354
2016
Q4
$184M Buy
2,225,354
+132,831
+6% +$11M 0.05% 369
2016
Q3
$194M Buy
2,092,523
+281,735
+16% +$26.1M 0.06% 347
2016
Q2
$141M Buy
1,810,788
+346,359
+24% +$26.9M 0.04% 405
2016
Q1
$121M Buy
1,464,429
+429,498
+42% +$35.4M 0.04% 468
2015
Q4
$108M Buy
1,034,931
+6,047
+0.6% +$633K 0.03% 493
2015
Q3
$108M Sell
1,028,884
-11,853
-1% -$1.25M 0.03% 501
2015
Q2
$142M Buy
1,040,737
+37,962
+4% +$5.19M 0.04% 442
2015
Q1
$125M Buy
1,002,775
+401,722
+67% +$50.1M 0.03% 510
2014
Q4
$54.3M Buy
601,053
+4,580
+0.8% +$414K 0.01% 848
2014
Q3
$43M Sell
596,473
-10,478
-2% -$756K 0.01% 957
2014
Q2
$37.8M Buy
606,951
+5,371
+0.9% +$334K 0.01% 1065
2014
Q1
$41M Sell
601,580
-3,929
-0.6% -$268K 0.01% 1007
2013
Q4
$42.6M Sell
605,509
-41,292
-6% -$2.9M 0.01% 971
2013
Q3
$46.7M Sell
646,801
-109,776
-15% -$7.92M 0.01% 905
2013
Q2
$42.2M Buy
+756,577
New +$42.2M 0.01% 927